News & Events
Stay updated
with us
Medicines360 is constantly evolving, and we want to keep you informed about our latest projects, partnerships, and achievements.
Press Releases
Learn more about significant announcements and developments at Medicines360 and the impact we are making in the field of women’s health.
-
FDA Approves Medicines360’s LILETTA® (levonorgestrel-releasing intrauterine system) 52 mg to Prevent Pregnancy for up to Eight Years
-
Medicines360 Calls on U.S. Congress to Pass Affordability is Access Act Without Delay
-
In the Wake of Supreme Court Decision, Medicines360 Stands With Women
-
Medicines360 Applauds HELP Committee for Including Critical Amendments on Nonprofit Pharma in Legislation Headed to Senate Floor
-
Medicines360 Applauds Sens. Rosen and Romney for Introducing Critical Legislation to Explore Benefits of Nonprofit Pharmaceutical Model
-
Medicines360 Appoints Elizabeth Garner, M.D., M.P.H. to Board of Directors
